P
Preventice Solutions
Developer of mobile health solutions and remote monitoring services that connect patients and caregivers
About Preventice Solutions
Preventice Solutions, now known as Boston Scientific Cardiac Diagnostics, operates in the healthcare technology market, specifically in the cardiac monitoring sector. The company's primary product is the BodyGuardian™ remote cardiac monitor, a wearable device designed to continuously track heart activity. This small, waterproof monitor can be worn 24/7, allowing patients to carry on with their daily lives while the device collects vital cardiac data.
The BodyGuardian™ is not just patient-friendly but also physician-friendly. It offers robust data collection capabilities and can be integrated with a wide range of electronic medical record (EMR) systems. This means the data collected by the monitor can be easily accessed and analyzed by physicians, aiding in accurate diagnosis and treatment.
Preventice Solutions serves two main types of clients: patients who need continuous cardiac monitoring and physicians who require reliable, real-time cardiac data for their patients. The company's business model is based on selling the BodyGuardian™ device to these clients, either directly or through healthcare institutions.
In terms of revenue generation, Preventice Solutions makes money by selling the BodyGuardian™ device and possibly offering additional services such as data analysis and EMR integration. The choice of business models mentioned on the company's website suggests that they may also offer different pricing or service packages based on the specific needs and resources of their clients.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES BOther financing | Jul 2020 | $137M | $548M | Boston Scientific · Vivo Capital · Novo Holdings · Merck Global Health Innovation Fund | ↗ |
| SEEDOther financing | Aug 2015 | $0 | — | Boston Scientific | — |
Growth signals
Latest recorded traffic for Preventice Solutions is 190 monthly website visits, down 86.4% over the last three months. Preventice Solutions's team declined 3.2% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Boston Scientific
Series A5 investors entered at this stage
Arthur Ventures
Vivo Capital
Novo Holdings
Merck Global Health Innovation Fund
Samsung Catalyst Fund
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Preventice Solutions on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Preventice Solutions’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







